Thirty six subjects were enrolled and showed responses as early ... on the skin of affected individuals. One of the most recent and perhaps most promising developments in psoriasis research ...
In the treatment of psoriasis, preliminary evidence supports the hypothesis that IL-23 inhibitors are capable of extended ...
Swiss pharmaceutical company Novartis has announced that a mid-stage ... psoriasis. Phase 2 data showed that AIN457 may significantly improve moderate-to-severe plaque psoriasis on the hands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results